Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Researchers at Oxford University's Nuffield Department of Primary Care Health Sciences have developed a new tool to predict people’s risks of getting oesophageal cancer in the next ten years.

Doctor examining a patient around the throat area

Researchers in the Nuffield Department of Primary Care Health Sciences at the University of Oxford have today unveiled a ground-breaking tool that could revolutionise the early detection of oesophageal cancer – the long tube that carries food from the throat to the stomach. This is the 8th most common cancer in the world. Using vast patient databases and cutting-edge computational techniques, the team has developed a prediction algorithm called ‘CanPredict (oesophageal)’ that identifies individuals at high risk of this cancer and could potentially save countless lives through targeted screening and early intervention.

Published today in ‘The Lancet Regional Health – Europe’ the team of researchers from the Universities of Oxford, Cambridge, and Nottingham developed this innovative tool to predict the 10-year risk of oesophageal cancer and to identify high-risk patients for further screening, potentially leading to earlier detection and improved patient outcomes. While there are methods available for detecting oesophageal cancer, such as endoscopy, they are often reserved for patients showing symptoms or those already known to be at high risk.

Read the full story on the University of Oxford website

Similar stories

Breakthrough in non-invasive liver testing

Two major international studies, including an imaging study led by researchers from the Radcliffe Department of Medicine, have provided new evidence on which non-invasive tests can accurately diagnose and measure the severity of metabolic dysfunction-associated steatotic liver disease (MASLD) and its more severe form, MASH, potentially reducing reliance on liver biopsy.

Researchers from the Nuffield Department of Primary Care Health Sciences contribute to parliamentary calls for overhaul of obesity care

Research from the Health Behaviors team has informed a series of parliamentary reports calling for urgent action to tackle obesity in England.

Oxford University invites 100,000 people to take part in a major study of plant-based diets

Researchers at the Nuffield Department of Population Health have launched a major new study designed to generate the most up-to-date picture of different diets in the UK, including plant-based diets, and how they affect long-term health and wellbeing.

Look beyond my skin: your psoriasis could help us understand who develops psoriatic arthritis

Adults with psoriasis across Europe are invited to take part in an online study aiming to identify who is at risk of developing psoriatic arthritis.

Professor Matthew Wood receives BioUK Special Recognition Award 2026

Professor Matthew Wood, Director and Chief Scientific Officer of the Oxford-Harrington Rare Disease Centre (OHC), has received BioUK’s Special Recognition Award 2026 for his contribution to rare disease research, therapeutic development and the wider life sciences sector.

University of Oxford and BIIE launch collaboration in translational immune engineering

Researchers from the Department of Paediatrics at the University of Oxford and the Botnar Institute of Immune Engineering (BIIE) came together in Oxford last week for the inaugural scientific meeting of the new Basel–Oxford Centre for Translational Immune Engineering for Child and Adolescent Health (CTIE).